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The catalytically active, tyrosyl-phosphorylated form of insulin receptor kinase was 
isolated from human placenta by a procedure which exploits the propensity for the 
intact are& form of insulin receptor to undergo insulin-promoted autophosphorylation 
at tyrosyl residues and concomitant activation as a tyrosyl kinase. Purification of tyrosyl- 
phosphorylated insulin receptor was effected by adsorption on and elution (with a hapten) 
from a column of 0-phosphotyrosyl-binding antibody immobilized on protein A-Se- 
pharose (Ab-protein A). The starting material for the purification process was protein 
which had been solubilized from placental membranes and purified by chromatography 
on immobilized wheat germ agglutinin. After chromatography on Ab-protein A to remove 
preexisting 0-phosphotyrosyl-containing proteins, the fraction which did not adsorb to 
the Ab-protein A column was incubated with insulin and briefly treated with ATP so 
as to maximize selective autophosphorylation of insulin receptor. This material was 
then subjected to chromatography on Ab-protein A. Although the amount of the intact 
(Y$& form of insulin receptor present in the starting material was only a small fraction 
of the protein (-0.2%) and only -20% of the insulin-binding forms of the receptor 
present, it was eluted (with 10 mM p-nitrophenyl phosphate) from the column in X30% 
purity. Chromatography on Ab-protein A appears to have an advantage over the alter- 
native affinity chromatographic procedures which utilize immobilized insulin or anti- 
insulin receptor antibody to adsorb insulin receptor, since these procedures do not resolve 
the intact c&& form of insulin receptor from the nicked insulin-binding forms of the 
receptor which do not undergo insulin promoted autophosphorylation. 0 1985 Academic 
Press, Inc. 
Several procedures have been published 
recently for purifying insulin receptor via 
affinity chromatography on immobilized 
insulin or immobilized receptor antibody 
[e.g., (l-S)]. These procedures, however, do 
not appear to yield homogeneous active in- 
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sulin receptor. A major difficulty is that 
the existing purification procedures based 
upon affinity chromatography do not re- 
solve the various insulin-binding forms of 
the receptor. Limited proteolysis of the /? 
subunits of the intact LV&~ tetrameric re- 
ceptor results in at least two additional in- 
sulin-binding forms of the receptor, (Y&&, 
and c&31)2 (9). These forms, together with 
others, have been shown to be present after 
affinity chromatography, on immobilized 
insulin (i’), of insulin receptor from human 
placenta which had been partially purified 
by chromatography on wheat germ agglu- 
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tinin (WGA): In our hands (lo), only 
-20% of the insulin-binding forms of in- 
sulin receptor is present as the intact CX& 
tetrameric receptor in preparations of 
WGA-purified insulin receptor from hu- 
man placenta. Since affinity chromatog- 
raphy on immobilized insulin would not be 
expected to separate the insulin-binding 
forms of insulin receptor, it is not surpris- 
ing that a highly heterogeneous mixture of 
insulin receptor is obtained by this method. 
The presence of multiple forms of the re- 
ceptor could complicate studies of its com- 
petence to function as a protein kinase, 
since only the intact adz form of the re- 
ceptor undergoes the insulin-mediated au- 
tophosphorylation reaction (10, 11) which 
induces the tyrosyl kinase activity of in- 
sulin receptor. These considerations un- 
derscored the need for an alternative pro- 
cedure for purification of insulin receptor, 
and prompted us to develop a procedure 
for isolating the intact LY& form of insulin 
receptor which exploits the unique ability 
of the CQ& form to undergo autophosphor- 
ylation. The procedure which is disclosed 
in this work involves adsorption (and spe- 
cific elution with hapten) of phosphory- 
lated insulin receptor on an immobilized 
antibody which binds 0-phosphotyrosyl 
residues. 
MATERIALS AND METHODS 
Materials. Histone H2b was obtained from Wor- 
thington; [Y-~P]ATP was from Amersham; keyhole 
limpet hemocyanin (KLH) was from Calbiochem- 
Behring; Angiotensin II and protein A-Sepharose 
were from Sigma; antireceptor antiserum was a gen- 
erous gift from Dr. C. Ronald Kahn; and N,N’-diace- 
4 Abbreviations used: KLH, keyhole limpet hemo- 
cyanin; Ab-protein A, 0-phosphotyrosyl binding an- 
tibody immobilized on protein A-Sepharose; BSA, 
bovine serum albumin; Mes, 4-morpholineethanesul- 
fonic acid; SDS, sodium dodecyl sulfate; SDS-PAGE, 
polyacrylamide gel electrophoresis done in the pres- 
ence of SDS, DTT, dithiothreitol; WGA, wheat germ 
agglutinin; Hepes, 4-(2-hydroxyethyl)-l-piperazine- 
ethanesulfonic acid, PBS, phosphate-buffered saline; 
GAR-HRP, goat anti-rabbit-horseradish peroxidase; 
PTC, phenylisothiocyanate; HT, Hepes-Triton buffer; 
KT, potassium phosphate-Triton buffer; TCA, tri- 
chloroacetic acid. 
tylchitobiose was generously supplied by Dr. Irwin 
Goldstein. 
N-Bromoacetyl-Gphosposphotyramine. This was pre- 
pared using a modification of a procedure described 
by Hartman (12) for bromoacetylating O-phospho- 
ethanolamine. 0-Phosphotyramine (1 g, 4.6 mmol), 
prepared according to published procedures (13,14), 
was dissolved in 20 ml of water and sufficient 5 M LiOH 
to bring the pH to 8.5. The resulting solution was 
stirred in a cooling bath (2O”C), and bromoacetyl bro- 
mide (8.8 g, 43.6 mmol) was added dropwise while 
maintaining the pH of the reaction mixture between 
7.5 and 8.5 by addition of 5 M LiOH. The clear solution 
was filtered, and evaporated to dryness under reduced 
pressure at 25°C. The resulting residue was macerated 
with ether (20 ml, 3X) followed by ethanol (40 ml, 3X), 
and was filtered each time to yield a residue (600 mg) 
of N-bromoacetyl-0-phosphotyramine dilithium salt. 
TLC (silica gel; n-BuOH:HAc:HzO, 7:2:5) indicated one 
spot with an R, of 0.49. The product was negative in 
a trinitrobenzenesulfonic acid test for primary amines 
(15), and contained no free phenolic groups as judged 
by the similar uv spectra obtained in water at pH 7 
and 12. 
0-Phosphotyramine-KLH conjugate. N-Bromoace- 
tyl-0-phosphotyramine dilithium salt (350 mg, 1 
mmol) was added in small lots to 27.5 mg of KLH in 
2.5 ml of 50 mM potassium phosphate buffer, pH 7.4, 
0.15 M NaCl (PBS). During the addition and for 96 h 
thereafter, the pH was maintained at 9.0-9.5 by ad- 
dition of 1 M LiOH. The reaction was terminated by 
subjecting the turbid reaction mixture to dialysis 
against PBS. The clear solution of KLH conjugate ob- 
tained after six changes of dialyzate was analyzed by 
uv spectrophotometry. The analysis, which indicated 
an incorporation of 4.1 0-phosphotyramine residues 
per 100 aminoacyl residues of KLH, was carried out 
using 
PI 
AAl, Au, and Au denote absorbance at Xl, x2, and X3. 
The subscripts c, p, and h denote conjugated protein, 
unmodified protein, and hapten model compound (N- 
bromoacetyl-0-phosphotyramine), respectively. [H] 
and [C] indicate the molar concentration of protein- 
linked haptenic groups and the concentration of pro- 
tein conjugate (in mg/ml), respectively. I is the in- 
corporation of hapten residues per 100 aminoacyl res- 
idues of protein assuming an average equivalent 
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weight of 100 for an aminoacyl residue. Values of 268 
nm, 280 nm, 290 nm, and ‘783 cm-’ M-I were used for 
the Xl, X2, X3, and (6X1)*, respectively. The values of 
(&)d(A& b&&4%&, and c!%h2 were 1.231.45, 
and 1.77. Determination of incorporation (I) using 
Eqs. [l]-[3] is based upon the assumption that the 
spectrum of the hapten is not perturbed by conjuga- 
tion to the protein and the observation that at X3 the 
contribution of the haptenic group to the absorbance 
is negligible relative to that of the protein. 
CXPhosphotyramine-BSA conjugate. This was pre- 
pared by reaction of 40 mg of BSA, dissolved in 2 ml 
of PBS, with N-bromoacetyl-0-phosphotyramine (350 
mg, 1 mmol) as described for the preparation of the 
KLH conjugate. 
Preparation of antisera. Antibody which binds O- 
phosphotyrosyl residues was raised in New Zealand 
white rabbits using the immunization procedure of 
Ross et al. (13) with the KLH conjugate of N-bro- 
moacetyl-0-phosphotyramine as antigen. The titer of 
the test antiserum was determined by an immunodot- 
blotting peroxidase assay using a goat anti-rabbit- 
horseradish peroxidase (GAR-HRP) conjugate as the 
second antibody (16). Antiserum to the KLH-phos- 
photyramine conjugate was tested for hapten speci- 
ficity against the BSA-phosphotyramine conjugate (3 
ng) adsorbed on nitrocellulose membranes using a Bio- 
Rad GAR-HRP assay kit. The suggested protocol was 
modified in that 0.05% Tween 20 in 20 mM Tris, 0.5 M 
NaCl, pH 7.5 (TBS) was used in the blocking and an- 
tibody buffer instead of the gelatin-TBS solutions. 
Additionally, 0.1 M Mes buffer, pH 6.0, was used instead 
of TBS for buffering the peroxidase-catalyzed reaction. 
Dilutions of antisera of l/500 through l/50,000 were 
tested for their ability to react with antigen. Antisera 
with titers in excess of l/25,000 were used for prep- 
aration of antibody. 
(;rPhasphotymmine-Sepharose. Sepharose 4B (10 ml 
packed gel) was activated with CNBr by the method 
of March et al. (17), and coupled to O-phosphotyramine 
using a modification of the procedure of Ross et al. 
(13). The activated slurry was filtered to a moist cake, 
and then transferred to a plastic bottle containing 
217 mg (1 mmol) 0-phosphotyramine which had been 
dissolved in 10 ml of 0.1 M NaHCOs and adjusted to 
pH 9.5 with 1 M NaOH. The reaction mixture was 
gently shaken at 4°C for 20 h and filtered. The re- 
sulting gel was transferred to 20 ml of 0.5 M glycine 
(pH 8.0) and shaken at 4°C for an additional 10 h. It 
was then filtered and washed according to the pro- 
cedure of March et al. (17). The washed gel was trans- 
ferred to a column, washed with water (until the 
washing showed no absorbance at 268 nm), and stored 
at 4°C. 
Determination of gel-linked Ophosphotyramine The 
gel was hydrolyzed according to the method of Mar- 
tensen (18) for liberating phosphotyrosine from pro- 
teins. The supernatant solution obtained after neu- 
tralization of the KOH with HClO, was treated with 
phenylisothiocyanate (PTC). The resulting PTC de- 
rivative of 0-phosphotyramine was quantified by high 
performance liquid chromatography (10) using PTC- 
0-phosphotyramine prepared from known amounts 
of 0-phosphotyramine as standards. The O-phospho- 
tyramine content of the gel was thus found to be 1.05 
fimol/ml. 
PurijEcation of O-phosphotyrosyl binding antibody. 
Antiserum (49 ml) was adjusted to 50 mM sodium flu- 
oride and 0.1 mM sodium vanadate by addition of the 
solid compounds. After standing at 4°C for 30 min 
the serum was centrifuged and the supernatant so- 
lution was applied to a 4.5 X 1.5 cm column of O- 
phosphotyramine-Sepharose which had been equili- 
brated at 4°C with 0.15 M NaCl, 10 mM potassium 
phosphate, pH 7.4. The column was washed succes- 
sively with 20 ml of 0.2 M KCl, 10 mM potassium phos- 
phate buffer, pH 7.4; 20 ml of 0.2 M potassium phos- 
phate, pH 7.4; and 20 ml of 50 mM Hepes buffer, pH 
7.6. Antibody was eluted (0.4 ml/min) from the column 
with 20 ml of 0.2 M p-nitrophenyl phosphate in 50 mM 
Hepes buffer (final pH, 7.4). The eluate was collected 
in l-ml fractions, and those fractions containing >0.4 
mg protein/ml were combined. The pooled solution of 
antibody was then dialyzed against four l-liter por- 
tions of 50 mM NaCl to remove the pnitrophenyl 
phosphate and yield 14 ml of solution containing 0.80 
mg/ml protein. The 0-phosphotyramine-Sepharose, 
which could be used repeatedly, was equilibrated with 
0.1 M potassium phosphate pH 7.4,0.02% sodium azide, 
and stored at 4°C. 
Immobilization of O-ph.osphotyrosyl binding antibody 
ox protein A-Sepharose. A protein A-Sepharose col- 
umn (3 ml, 3.9 X 1.0 cm) was equilibrated with 50 mM 
Hepes, pH 7.6,0.1% Triton X-100 (HT), and 0.9 ml of 
the solution of purified antibody (0.8 mg/ml) was ap- 
plied to the column. After the antibody solution ran 
down to the top of the gel, the flow was stopped and 
the column was left at room temperature for 45 min. 
The resulting Ab-protein A column was washed with 
15 ml of 0.2 M potassium phosphate, pH 7.5,0.1% Triton 
X-100 (KT), equilibrated with 0.02% sodium azide, and 
stored at 4°C. 
Purificaticm of phosphorylated insulin receptor. In- 
sulin receptor was isolated from human placenta and 
partially purified by chromatography on immobilized 
WGA as previously described (3, 19). To remove 
preexisting phosphotyrosyl-containing proteins, the 
eluate from WGA-agarose (27 ml, 1 mg/ml protein 
from 1.5 human placentas) was passed (at 4°C) 
through a 3-ml column of Ab-protein A, which had 
been previously washed with 15 ml of KT and equil- 
ibrated with HT. The column was then washed with 
3 ml HT and the wash was combined with the flow- 
through. 
The resulting solution was mixed with 0.3 ml of 10 
pM insulin and 75 ~1 of 2 M MnClr, and then incubated 
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for 30 min at room temperature. Autophosphorylation 
was initiated by the addition of 75 ~1 of 20 mrd ATP, 
and was terminated after 5 min by addition of 1.2 ml 
of 0.25 M EDTA, pH 7.6, and 56 mg NaF. The reaction 
mixture was then cooled in an ice bath, and passed 
through a l-ml Ab-protein A column at 4°C which 
had been washed with KT and equilibrated with HT. 
The column was then washed with 10 ml of 0.15~ 
NaCl in HT. After a wash with 10 ml HT, the column 
was eluted with 4 ml of 10 mMpnitropheny1 phosphate 
in HT. The first 0.5 ml of eluate contained no receptor 
and was discarded. The remainder of eluate which 
contained insulin receptor was collected. The Ab-pro- 
tein A column was regenerated by washing with KT. 
No apparent change in the capacity was observed after 
it had been used more than ten times. During the 
purification procedure care was taken to prevent so- 
lutions of the receptor from contacting metals, since 
this can result in a large decrease in the activity of 
the receptor. [The inhibition of the receptor kinase 
by metal ions is described in Ref. (20).] Addition of 1 
mM DTT to the wash and elution buffers did not affect 
the specific kinase activity of the purified receptor. 
Protein assays. Bio-Rad protein assay dye reagent 
(21) was used for the estimation of protein in the 
WGA-purified receptor and in affinity-purified O- 
phosphotyrosyl binding antibody, with ovalbumin and 
rabbit IgG as the protein standards, respectively. For 
estimation of protein content in the Ab-protein A- 
Sepharose eluate, a Zeineh soft laser scanning den- 
sitometer (Biomed Instruments, Inc., Model Sl-TRFF) 
was used for density measurements of the 95- and 
125-kDa bands in the silver-stained gels which were 
developed according to the method of Morrissey (22). 
The protein content in these two bands was estimated 
from a linear standard curve relating density to pro- 
tein content; the standard curve was prepared using 
ovalbumin (50-400 ng) as the reference standard. 
Assays of kinase activity. Two kinase assay proce- 
dures, with both histone H2b and angiotensin II as 
substrates, were used to determine the activity of the 
receptor at different stages of purification. In assay 
I, a sample of receptor in 10 ~1 was adjusted to a vol- 
ume Of 70 ~1 so as t0 Contain 0.71 PM insulin, 0.43 mg/ 
ml histone H2b, 28.6 mM Hepes, pH 7.6,0.057% Triton 
X-100, and 5.7 mM MnC12. In the case of phosphory- 
lated, WGA-purified receptor, 1.4 mM pnitrophenyl 
phosphate was included. This was done so that the 
conditions of the assays of the antibody-purified and 
WGA-purified receptor would be similar. Separate 
studies indicated that the 1.4 mM p-nitrophenyl phos- 
phate had no substantial effect on the assay. Insulin 
was included in all assays unless otherwise indicated. 
After a lo-min incubation at room temperature, 
phosphorylation was initiated by addition of 10 ~1 of 
0.2 mM [@‘P]ATP (sp act, 2000-4000 cpm/pmol). 
Phosphorylation was allowed to proceed for 15 min 
at room temperature (23-25”C), whereupon the re- 
action was quenched by heating with SDS sample 
buffer, and subjected to SDS-PAGE with an 11.3% 
separation gel. After staining, destaining, and drying, 
the histone bands were excised from the dried gel and 
counted by the Cerenkov method. When angiotensin 
II was used as substrate, 2.9 mM angiotensin was used 
in place of the 0.43 mg/ml histone H2b. After the 
reaction was quenched by addition of 25 ~120% TCA, 
the phosphorylated peptide was absorbed on phos- 
phocellulose paper and quantified as described by 
Staudtmauer and Rosen (23). 
Assay II was also used for determination of the 
kinase activity of the receptor purified by chroma- 
tography on Ab-protein A. It was identical to assay 
I described above except that 10 ~1 of the eluate from 
the Ab-protein A column was assayed in the presence 
of 10 pl phosphorylated, WGA-purified receptor. The 
activity of the receptor in the eluate was obtained by 
subtracting from the total activity the contribution 
from the WGA-purified receptor determined in the 
presence of p-nitrophenyl phosphate. 
Immunoprecipitation of insulin receptor. A solution 
of insulin receptor in HT (50 ~1) was mixed with 0.5 
~1 B-9 antireceptor antiserum. After a 2-h incubation 
at 4°C 20 ~1 of a 50% suspension of protein A-Se- 
pharose in HT was added to the mixture, and the re- 
sulting suspension was shaken on a rotatory shaker 
for 2 h at 4°C. The suspension was then centrifuged 
and the supernatant solution was removed. The re- 
maining pellet was washed twice with 0.5 ml of 0.15 
M NaCl in HT and once with 0.5 ml HT. For analyses 
wherein the kinase activity was to be determined, 10 
~1 of supernatant solution or the entire pellet were 
used as samples in assay I with histone H2b as sub- 
strate. In analyses wherein %P-labeled receptor was 
to be determined, the entire supernatant and the en- 
tire pellet from the immunoprecipitation were sepa- 
rately adjusted to a volume of 80 ~1 with water after 
addition of 20 ~1 of a fourfold concentrated SDS sam- 
ple buffer of Laemmli (24) but without thiol. Samples 
of these solutions (50 ~1) were subjected to SDS-PAGE 
with a 4.5% separation gel. 
SDS-PAGE. This was performed as described by 
Laemmli (24). For nonreduced receptor, a 4.5% sep- 
aration gel with acrylamide and N,N’-methylenebis- 
acrylamide in a ratio of 1OO:l was used. For reduced 
receptor and kinase assays with histone H2b as sub- 
strate, 7.5 and 11.3% gels were used, respectively, with 
acrylamide and NJ’-methylenebisacrylamide in a 
ratio of 3O:O.S. 
Other procedures. Iodination of insulin, crosslinking 
of insulin receptor with lzI-insulin, and other pro- 
cedures were carried out as described previously 
(10, 19). 
RESULTS AND DISCUSSION 
Insulin receptor from human placental 
tissue was solubilized and partially purified 
180 PANG, SHARMA. 
by lectin chromatography on immobilized 
WGA. The WGA-purified receptor was 
then passed through a column of O-phos- 
photyrosyl binding antibody immobilized 
on protein A-Sepharose to remove preex- 
isting phosphotyrosyl-containing proteins. 
The fraction which did not bind to the col- 
umn was incubated with insulin and 
treated briefly with ATP to effect specific 
autophosphorylation of the insulin recep- 
tor. This reaction mixture was applied to 
a column of immobilized O-phosphotyro- 
syl-binding antibody. After washing the 
column, phosphorylated insulin receptor 
was eluted with 10 mMp-nitrophenyl phos- 
phate (Fig. 1). 
The feasibility of using antibodies re- 
active toward the phenyl phosphate group 
for purification of O-phosphotyrosyl-con- 
taining proteins was first demonstrated by 
Ross et al. (13), who used such antibodies 
in the purification of O-phosphotyrosyl- 
containing proteins from virally trans- 
formed cells. Our application of this ap- 
proach to the purification of the insulin 
receptor involved some important modifi- 
cations, however. The antibodies were 
raised using as antigen a KLH conju- 
gate of N-bromocetyl-0-phosphotyramine 
rather than the KLH conjugate of pazo- 
benzyl phosphonate used by Ross et al. (13), 
since, as indicated by Ross et al. (13), the 
use of an antigen closer in structure to an 
0-phosphotyrosyl residue than pazobenzyl 
phosphonate would be expected to yield 
antibody with a higher affinity for O-phos- 
photyrosyl residues in proteins. To further 
enrich our antibody preparation in anti- 
bodies with a high affinity for O-phospho- 
tyrosyl residues, we used 0.2 M (rather than 
10 InM) phosphate buffer to wash antibody 
which was bound to O-phosphotyrosine- 
Sepharose during purification of the anti- 
body by affinity chromatography. Although 
this higher concentration of phosphate re- 
moved weakly binding antibody, the phos- 
phate grouping was still a major deter- 
minant of the antibody-hapten interaction. 
Thus, high concentrations of phosphate 
buffer (0.2 M) could elute insulin receptor 
from the immobilized purified antibody 
(data not shown). Finally, rather than im- 









FIG. 1. Specific elution of autophosphorylated insulin 
receptor from immobilized 0-phosphotyrosyl-binding 
antibody. Autophosphorylated (with [y-“PIATP) in- 
sulin receptor from 1.5 placentas in 20 ml was sub- 
jected to chromatography on immobilized O-phos- 
photyrosyl-binding antibody. Samples (40 ~1) were 
analyzed (after reduction) by SDS-PAGE (7.5% gel) 
with silver staining. The samples analyzed were the 
initial reaction mixture (A), the flow-through (B), and 
two washes (2 ml each) consisting of the following 
solutions: 0.15 M NaCl in HT (C, D); 10 mM pnitro- 
phenyl a-D-galactopyranoside in HT (E, F); 10 mM DL- 
phosphothreonine in HT (G, H); 10 mM DL-phospho- 
serine in HT (I, J); and 10 mM potassium phosphate 
in HT (K, L). The autophosphorylated form of the 
receptor was then eluted with five 2-ml portions of 10 
mM pnitrophenyl phosphate in HT (M-Q). Finally, 
the column was washed with 2 ml of 0.2 M potassium 
phosphate, pH 7.5,0.1% Triton X-100 (R). The arrows 
denote the migration position of P-galactosidase 
(116K), phosphorylase (94K), bovine serum albumin 
(66K), and ovalbumin (45K). (A) Silver-stained gel; 
(B) autoradiogram of the same gel. 
it directly to chemically activated Sephar- 
ose, we immobilized it by adsorption on 
protein A-Sepharose. This immobilization 
procedure not only effected further puri- 
fication of the antibody by eliminating any 
non-IgG contaminants, but also yielded 
gels having a higher capacity to bind phos- 
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phorylated insulin receptor than gels pro- 
duced by reaction of the purified antibody 
with chemically activated Sepharose. 
The silver-stained and autoradiographed 
SDS-PAGE gels depicted in Figs. 1A and 
B, respectively, illustrate noteworthy as- 
pects of the chromatography of insulin re- 
ceptor on immobilized O-phosphotyrosyl- 
binding antibody. Lanes A and B of Fig. 
IA indicate that most of the protein applied 
to the Ab-protein A column was not ad- 
sorbed. Lanes E-J show that compounds 
having structural features in common with 
p-nitrophenyl phosphate such as p-ni- 
trophenyl a-D-galactopyranoside, DL-O- 
phosphothreonine, and DL-O-phosphoser- 
ine failed (at concentrations of 10 mM) to 
elute significant quantities of insulin re- 
ceptor from the column. Phosphate ion at 
a concentration of 10 mM, however, did 
elute a small amount of receptor from the 
column. Washes E-L of Fig. 1 were used to 
determine the specificity of elution with 10 
mMpnitropheny1 phosphate. These washes 
failed to remove nonreceptor protein from 
the column, and were omitted from sub- 
sequent chromatographic procedures (see 
Materials and Methods) with no decrease 
in product purity. The two major bands, at 
125 and 95 kDa, shown in Fig. 1, lane M, 
are attributed to the (Y and ,0 subunits of 
the insulin receptor in the eluate from the 
Ab-protein A column.5 As expected when 
the WGA-purified insulin receptor was 
phosphorylated with [T-~~P]ATP, the mo- 
bility of the predominant species which 
was radiochemically labeled with 32P cor- 
responded to that of the P-subunit of the 
purified insulin receptor (Fig. 1B).5 
The intact cr2f12 form of the receptor was 
eluted from the Ab-protein A column (with 
’ Close inspection of Fig. 1A reveals barely detect- 
able bands in the region of 50 kDa. These bands which 
become more prominent on overexposure to the silver 
stain are present when buffer is electrophoresed in 
the presence of thiols in the absence of receptor. Con- 
tamination by bacteria may be responsible for the 
appearance of these bands which have been reported 
by other investigators (25). Labeling of components 
in addition to the 95-kDa 0 subunit is barely detectable 
in Fig. 1B. This labeling, however, corresponds to only 
a small fraction of the radiochemical label incorpo- 
rated into the fl subunit. 
10 mM p-nitrophenyl phosphate) in greater 
than 80% purity as judged from the relative 
intensities of the 370- and 320-kDa bands 
produced by SDS-PAGE in the absence of 
reductant (Fig. 2). Overexposure of the gel 
in Fig. 2 to the silver stain resulted in a 
uniform increase in the intensity of the 
background with the appearance of no ad- 
ditional bands. When the WGA-purified 
receptor was phosphorylated in the pres- 
ence of [T-~~P]ATP and then chromato- 
graphed on Ab-protein A, the 32P label was 
present in both the 370- and 320-kDa pro- 
teins (Fig. 3, lane 2). The fact that little or 
no labeling of the 320-kDa protein was seen 
immediately after the WGA-purified re- 
ceptor was phosphorylated (Fig. 3, lane 1) 
suggests that the 320-kDa protein was 
produced by proteolysis of intact receptor 
subsequent to phosphorylation. As ex- 
pected, both the 320- and 3’70-kDa proteins 
FIG. 2. SDS-PAGE of the insulin receptor before 
and after purification on immobilized O-phosphoty- 
rosyl-binding antibody. After autophosphorylation, 
samples were subjected to SDS-PAGE (4.5% gel) 
without reduction. Lane 1 is a sample of WGA-purified 
receptor that was applied to the immobilized antibody 
column. Lane 2 is a sample of the material eluted 
from the column by 10 mM pnitrophenyl phosphate. 
Shown is a silver-stained gel. 






FIG. 3. Evidence for proteolysis during purification. 
WGA-purified receptor was phosphorylated in the 
presence of [y-“PJATP. Samples, before and after pu- 
rification by chromatography on immobilized O- 
phosphotyrosyl-binding antibody, were analyzed by 
SDS-PAGE (4.5% gel) without reduction. Autoradio- 
grams of the dried gels are shown. Lane 1, EDTA- 
quenched reaction mixture; lane 2, purified receptor. 
were precipitated by antibody to insulin 
receptor (Fig. 4). 
Affinity crosslinking of the purified 
phosphorylated receptor with ?-insulin 
followed by SDS-PAGE and autoradiog- 
raphy produced a major diffuse band with 
an electrophoretic mobility corresponding 
to that of the intact a& form of the re- 
ceptor (Fig. 5). The ability to crosslink ‘%I- 
insulin to the purified, phosphorylated in- 
sulin receptor is consistent with results of 
previous studies (10) wherein the double- 
probe labeling method was used to show 
that insulin receptor molecules in a WGA- 
purified preparation of the receptor re- 
tained their competence to bind insulin af- 
ter autophosphorylation. Comparison of 
lanes A and C of Fig. 5 reveals that the 
insulin-binding, fragmented forms of the 
receptor predominant in the WGA-purified 
receptor are almost eliminated by chro- 
matography on immobilized O-phospho- 
tyrosyl-binding antibody. The ability of 
this procedure to purify selectively the in- 
tact a.$& form of the insulin receptor is at- 
tributed to the fact that only the intact adz 
form undergoes insulin-promoted auto- 
phosphorylation during the brief treat- 
ment with ATP, and therefore only this 
form of the receptor is retained by the 
phosphotyrosine-binding antibody. 
The 125:95 mass ratio of the (Y and fi sub- 
units might be expected to produce an in- 
tensity ratio of about 1:0.76 in silver- 
stained gels, provided that both subunits 
have a similar content of aminoacyl resi- 
dues, which are responsive to the silver 
stain. An intensity ratio of 1:0.45 was ob- 
served, however, for the bands corre- 
sponding to the (Y and B subunits. This re- 
sult might be due to both a lower reactivity 
of the p subunit toward the silver stain and 
a partial degradation of the p subunit in 
the 320-kDa minor component. Close ex- 
amination of Fig. 1, lane M, reveals a minor 
band at 45 kDa which is attributed to the 
fragmented 6 chain of the 320-kDa minor 
component. 
In an experiment designed to determine 
whether phosphorylated insulin receptor 
370K* 
320K - 
FIG. 4. Immunoprecipitation of purified insulin re- 
ceptor purified by chromatography on Ab-protein A. 
Purified, q-labeled receptor was immunoprecipitated 
by an antireceptor antiserum (B-9). The immunopre- 
cipitate (1) and supernatant (2) were analyzed by SDS- 
PAGE (4.5% gel) without reduction. Shown is an au- 
toradiogram of the dried gel. 
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FIG. 5. Affinity crosslinking of insulin receptor be- 
fore and after chromatography on Ab-protein A. 
WGA-purified receptor and receptor purified by chro- 
matography on Ab-protein A were affinity-labeled 
with lzI-insulin (20 nM) and disuccinimidyl suberate 
(0.3 mM), and electrophoresed in a 4.5% gel in the ab- 
sence of reductant. Shown is an autoradiogram of the 
dried gel. WGA-purified receptor (14 pg) affinity-la- 
beled with ‘?-insulin in the absence (A) and the 
presence (B) of unlabeled insulin (0.2 PM). Receptor 
(50 ng) purified by chromatography on Ab-protein A 
was labeled in the absence (C) and the presence (D) 
of unlabeled insulin (0.2 jtM). The inhibition of cross- 
linking of ‘l-insulin by excess unlabeled insulin 
shown in lanes B and D demonstrates the specificity 
of the affinity crosslinking. The electrophoretic mo- 
bilities of the (&)a, (@)((Y&), and (&)a forms of in- 
sulin receptor correspond to those of proteins with 
M,‘s of 340K, 320K, and 290K, respectively. Introduc- 
tion of crosslinks has been shown (10) to decrease the 
electrophoretic mobility of insulin receptor and also 
to cause insulin receptor bands to become more diffuse 
(10). The presence of crosslinks, which probably pre- 
vent the protein from unfolding completely in SDS, 
are responsible for the reduction from 370K (Fig. 2) 
to 340K in the apparent Jl, of the (a/~‘)~ form of insulin 
receptor. 
contained bound insulin after it had been 
purified by chromatography on Ab-protein 
A, WGA-purified insulin receptor was 
phosphorylated (with [T-~~P]ATP) using 
N ‘BB-biotinylinsulin instead of insulin 
to promote receptor autophosphorylation. 
The resulting phosphorylated receptor was 
purified by chromatography on Ab-protein 
A in the usual manner, and immediately 
crosslinked with 0.3 mM disuccinimidyl 
suberate. The 32P-labeled, crosslinked in- 
sulin receptor was then subjected to SDS- 
PAGE in the presence and absence of suc- 
cinylavidin. The observation that succi- 
nylavidin did not alter the electrophoretic 
mobility of the 32P-labeled receptor indi- 
cated the absence of significant amounts of 
bound biotinylinsulin (data not shown). 
Control experiments wherein phosphory- 
lated receptor was crosslinked in the pres- 
ence of added N’BB-biotinylinsulin yielded 
32P-labeled, crosslinked receptor whose 
electrophoretic mobility was decreased by 
succinylavidin as previously reported (10). 
A comparison of the kinase activity (to- 
ward histone H2b) of the WGA-purified 
receptor and that of the intact phosphor- 
ylated receptor is shown in Fig. 6. In ad- 




Insulin -+ -+ 
FIG. 6. Insulin-dependent phosphorylation of his- 
tone by phosphorylated receptor. Histone was phos- 
phorylated by 14 pg WGA-purified receptor (lanes 1, 
2) and 28 ng phosphorylated receptor purified by 
chromatography on Ab-protein A (lanes 3, 4) in the 
absence (lanes 1, 3) and the presence (lanes 2, 4) of 
0.63 pM insulin as described under Materials and 
Methods. Shown is an autoradiogram of the dried gel. 
The appearance of two histone bands is attributed to 
the presence of histones H2a and H2b. Protein-stain- 
ing of this commercially obtained histone H2b also 
yielded two histone bands. 
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TABLE I 





Assay I Assay II 
Angiotensin Histone Angio- Histone 
II H2B tensin II H2B 
Phosphorylated WGA-purified 
receptor 20.7 1035 (50) 1056 (51) 
Ab-Protein A ehromatog- 
raphy flow-through 20.7 435 (21) 435 (21) 
Eluate 0.0099 267 (27,000) 257 (26,000) 545 (55,000) 554 (56,000) 
Note. The determinations of protein concentration and kinase activity were performed as described under 
Materials and Methods. A kinase unit is defined as that amount of enzyme that will catalyze incorporation 
of 1 pmol of phosphate into substrate per minute under the assay conditions. Specific activity, in kinase units 
per milligram protein, is given in parentheses. 
dition to the increased kinase activity of 
the purified phosphorylated receptor (note 
the use of 500 times less protein with the 
purified phosphorylated receptor), the ac- 
tivity of the purified phosphorylated re- 
ceptor was not affected by insulin. This ob- 
servation, together with the findings in- 
dicating that the purified intact receptor 
contains little or no bound insulin, confirms 
the conclusion of Rosen et al. (26) that in- 
sulin-promoted receptor phosphorylation 
activates the receptor as a kinase toward 
exogenous substrates, and that insulin does 
not affect the activity of the phosphory- 
lated receptor.6 
The recovery of the receptor kinase ac- 
tivity and the degree of purification real- 
ized by chromatography on Ab-protein A 
can be determined from the data in Table 
I. The data in Table I indicate that only 
about 60% of the kinase activity was ad- 
sorbed on the Ab-protein A column. The 
inability to adsorb 100% of the kinase ac- 
tivity did not appear to be due to use of 
insufficient Ab-protein A, as judged by the 
absence of significant quantities of phos- 
phorylated insulin receptor in the flow- 
through (Fig. lB, lane B) and the obser- 
vation that passage of the unadsorbed 
kinase over a regenerated column of Ab- 
protein A failed to adsorb significant ki- 
nase activity. A substantial fraction of the 
unadsorbed kinase activity may reflect the 
presence of protein kinases which were not 
tyrosine-phosphorylated during the short 
(5 min) incubation with ATP in the pres- 
ence of insulin as well as incompletely 
phosphorylated insulin receptor. The data 
of Table I indicate that only 270 of the 
-600 kinase enzyme units adsorbed on the 
Ab-protein A column were recovered as 
judged by direct assays of the kinase ac- 
tivity toward histone H2b and angiotensin 
II. This deficit in kinase units might be at- 
tributed in part to differences in the com- 
position of the samples assayed or the 
presence of an activating factor in the 
WGA-purified receptor (or both), since as- 
say of the eluate from the Ab-protein A 
column in the presence of the WGA-puri- 
fied receptor (according to assay II wherein 
the activity of the added material was sub- 
tracted from the total activity) showed that 
greater than 90% of the -600 kinase units 
adsorbed to the column was recovered in 
‘This conclusion is further supported by the ob- 
the eluate. The observation (data not 
servation of Rosen et al (26) that alkaline phosphatase 
shown) that bovine serum albumin is al- 
treatment of partially purified phosphorylated insulin most as effective as the WGA-purified re- 
recentor restores the insulin sensitivity of the kinase ceptor in assay II suggests, however, that 
activity. most of the deficit in kinase units is due to 
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losses of protein by adsorption on surfaces 
which often become significant in the 
transfer of dilute solutions of proteins. The 
ratio of the specific activities of the eluate 
and that of the WGA-purified antibody in- 
dicated that the chromatography of Ab- 
protein A effected an approximately 500- 
fold purification of insulin receptor kinase 
from human placenta. Purified insulin re- 
ceptor was stored under liquid nitrogen, 
where its kinase activity remained unal- 
tered for several weeks. 
It is important to note that this purifi- 
cation procedure relies on specific auto- 
phosphorylation of the insulin receptor in 
the preparation of the WGA-purified re- 
ceptor which had been passed through a 
column of Ab-protein A to adsorb any 
preexisting phosphotyrosyl-containing 
protein. Since the crude preparation may 
contain several receptor protein kinases 
and other proteins which might undergo 
tyrosyl phosphorylation upon incubation 
with ATP, care was taken to preincubate 
the preparation with insulin and quench 
the reaction 5 min after the addition of 
ATP. The degree of success of this ap- 
proach is reflected in silver-stained and 
autoradiographed gels depicted in Figs. l- 
4, which show that almost all of the purified 
material migrated in the positions expected 
for the insulin receptor and precipitated 
with antireceptor antibodies. Furthermore, 
the data in Table II indicate that anti-in- 
sulin receptor antibody precipitated 83% 
of the kinase activity of phosphorylated 
insulin receptor which had been purified 
by chromatography on Ab-protein A. This 
observation suggests that most, if not all, 
of the measured kinase activity is an in- 
tegral part of the purified phosphorylated 
insulin receptor or tightly associated with 
it, and that if present, extraneous contam- 
inating kinases are minor contributors 
(~1’7%) to the observed kinase activity. 
Thus, chromatography of insulin recep- 
tor on 0-phosphotyrosyl-binding antibody 
immobilized on protein A-Sepharose ap- 
pears to yield the catalytically active form 
of insulin receptor kinase. This material, 
which is nearly homogeneous, should be 
suitable for studies of the relationship be- 
tween receptor structure and catalytic 
competence toward exogenous substrates. 
Studies of the insulin-promoted autophos- 
phorylation event will, of course, require 
the unphosphorylated form of the receptor 
which is not directly obtained by the pro- 
cedures described in the present paper. 
Although the purification of insulin re- 
ceptor by affinity chromatography on im- 
mobilized insulin and by chromatography 
on immobilized phosphotyrosyl-binding 
antibodies reported in this work yields dif- 
ferent forms of the receptor, the latter 
procedure appears to offer some advan- 
tages over the former. The highest degree 
of purification of WGA-purified insulin re- 
ceptor kinase has been obtained recently 
by Rosen and her co-workers (8), who made 
TABLE II 










Kinase activity (cpm) 
Supernatant Pellet 
9,828 14,161 
2 Ah-protein A-Sepharose 
eluate 
0.048 4,710 22,759 
Note. Immunoprecipitation and kinase assays were carried out as described under Materials and Methods. 
The listed kinase activities (with histone H2h as substrate) were obtained by Cerenkov counting of the excised 
histone gel bands. The kinase activity listed for the supernatant is six times the observed incorporation of 
BP into histone to correct for the fact that only l/6 of the supernatant solution was assayed. Thus, 83% (22,759 
X 100/22,759 + 4,710) of the kinase activity of the purified receptor was precipitated by the anti-insulin 
receptor antibody. 
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the important discovery that the presence 
of DTT during affinity chromatography 
markedly enhanced the specific activity of 
the recovered insulin receptor kinase. The 
WGA-purified insulin receptor kinase ac- 
tivity, however, could only be purified by 
llO- to 131-fold even in the presence of di- 
thiothreitol? This purification factor is 
about 4-fold lower than that which we ob- 
tained by subjecting the WGA-purified re- 
ceptor to chromatography on immobilized 
phosphotyrosyl-binding antibodies.* The 
higher degree of purification obtained by 
chromatography on immobilized phospho- 
tyrosyl-binding antibodies is attributed to 
the ability of this method to resolve the 
phosphorylated form of the receptor which 
is active as a kinase from the other (un- 
phosphorylated) forms of insulin receptor 
which appear to be devoid of tyrosyl kinase 
activity. 
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